T. Rowe Price Associates’s Ducommun DCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24M Buy
10,183
+2,232
+28% +$267K ﹤0.01% 2041
2025
Q4
$757K Buy
7,951
+413
+5% +$38.5K ﹤0.01% 2207
2025
Q3
$725K Buy
7,538
+642
+9% +$58K ﹤0.01% 2210
2025
Q2
$570K Buy
6,896
+950
+16% +$63.1K ﹤0.01% 2243
2025
Q1
$346K Buy
5,946
+649
+12% +$41K ﹤0.01% 2404
2024
Q4
$338K Buy
5,297
+846
+19% +$54.3K ﹤0.01% 2458
2024
Q3
$294K Buy
4,451
+168
+4% +$10.5K ﹤0.01% 2485
2024
Q2
$249K Buy
+4,283
New +$239K ﹤0.01% 2502
2022
Q2
Sell
-3,848
Closed -$202K 2972
2022
Q1
$202K Buy
+3,848
New +$183K ﹤0.01% 2709
2021
Q3
Sell
-3,825
Closed -$209K 2949
2021
Q2
$209K Buy
3,825
+198
+5% +$11.3K ﹤0.01% 2715
2021
Q1
$218K Buy
+3,627
New +$203K ﹤0.01% 2661
2020
Q3
Sell
-6,559
Closed -$229K 2597
2020
Q2
$229K Buy
+6,559
New +$194K ﹤0.01% 2326
2020
Q1
Sell
-6,478
Closed -$327K 2526
2019
Q4
$327K Buy
6,478
+428
+7% +$19.7K ﹤0.01% 2290
2019
Q3
$257K Buy
6,050
+56
+0.9% +$2.42K ﹤0.01% 2336
2019
Q2
$270K Buy
+5,994
New +$269K ﹤0.01% 2333

Other funds holding DCO

T. Rowe Price Associates's DCO Position: Q1 2026 in Review

T. Rowe Price Associates increased its Ducommun (DCO) stake by 28% in Q1 2026, buying an estimated $267K and bringing the position to 10,183 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2041.

T. Rowe Price Associates first reported a position in DCO in Q2 2019 and has held it in 15 quarters since. 224 funds tracked by Wall St. Rank hold DCO as of Q1 2026.

  • T. Rowe Price Associates held 10,183 shares of Ducommun worth $1.24M as of Q1 2026.
  • T. Rowe Price Associates bought 2,232 Ducommun shares in Q1 2026, an estimated $267K.
  • Ducommun made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2041 holding.
  • T. Rowe Price Associates first reported a position in Ducommun in Q2 2019 and has held it in 15 quarters since.
  • 224 funds tracked by Wall St. Rank held Ducommun as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.